Low-dose Digital Radiographs in the Idiopathic Scoliosis

Sponsor
Istituto Ortopedico Rizzoli (Other)
Overall Status
Unknown status
CT.gov ID
NCT03464318
Collaborator
(none)
50
1
35.2
1.4

Study Details

Study Description

Brief Summary

The aim of the study is to evaluate the intraobserver repeatability and the interobserver reproducibility of low-dose radiographs with a HELIOS DRF (CAT) imaging system in patients with idiopathic scoliosis.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The 80% of scoliosis is idiopathic and begins mostly in adolescence (10-20 years).

    The young patients need to undergo several radiographic controls for a correct therapeutic balance. However, the repeated radiation exposures is associated with a greater risk of carcinogenesis even if reduced with a digital imaging technique.

    The aim of this study is to evaluate the intraobserver repeatability and the interobserver reproducibility of low-dose radiographs with a HELIOS DRF (CAT) imaging system in patients with idiopathic scoliosis.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    50 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Repeatability and Reproducibility of Low-dose Digital Radiographs in the Idiopathic Scoliosis
    Actual Study Start Date :
    Jan 27, 2018
    Anticipated Primary Completion Date :
    Jan 1, 2021
    Anticipated Study Completion Date :
    Jan 1, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Repeatability and reproducibility [baseline (day 0)]

      Repeatability and reproducibility of the Cobb angle measurement

    Secondary Outcome Measures

    1. Repeatability and reproducibility [baseline (day 0)]

      Repeatability and reproducibility of kyphosis angle, lordosis angle, lumbosacral angle, Nash-Moe rotation index and Risser index measurement

    2. Radiation exposure [baseline (day 0)]

      collection of dosimetric data

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    9 Years to 20 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patients with suspected or known idiopathic scoliosis

    • patients able to maintain orthostasis without medical devices

    • patients from 9 to 20 years old

    Exclusion Criteria:
    • patients with known congenital, syndromic, neurological scoliosis

    • patients not able to maintain orthostasis

    • obese patients

    • low back pain or known tumor pathology

    • patients with vertebral arthrodesis

    • patients younger than 9 years old, or older than 20 years old

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Rizzoli Orthopaedic Institute Bologna Italy 40136

    Sponsors and Collaborators

    • Istituto Ortopedico Rizzoli

    Investigators

    • Principal Investigator: Milva Battaglia, MD, Rizzoli Orthopaedic Institute

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Milva Battaglia, Principal Investigator, Istituto Ortopedico Rizzoli
    ClinicalTrials.gov Identifier:
    NCT03464318
    Other Study ID Numbers:
    • RXbd17
    First Posted:
    Mar 14, 2018
    Last Update Posted:
    Jan 16, 2019
    Last Verified:
    Jan 1, 2019
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Milva Battaglia, Principal Investigator, Istituto Ortopedico Rizzoli
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 16, 2019